Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2024-08-08 00:00:00 ET · period of report 2024-08-06 · accession 0000950170-24-094117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-08 | 2024-08-06 | BBIO | Trimarchi Thomas | Pres, COO | A - Grant | $0.00 | +19.0K | 413.9K | +5% | $0 |
| D | 2024-08-08 | 2024-08-06 | BBIO | Trimarchi Thomas | Pres, COO | A - Grant | $0.00 | +3,160 | 3,160 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-06 | A | A | 19,003 | $0.00 | 413,859 | D | — | — | (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-08-06 | A | A | 3,160 | $0.00 | 3,160 | D | $24.87 · — to 2034-08-05 | 3,160 Common Stock | (F3) The stock option shall vest in 16 quarterly installments beginning on August 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. |